unknown
Stage
About
BioEclipse Therapeutics develops allogeneic and autologous immunotherapies designed to treat resistant and recurrent solid tumors by programming immune cells to attack cancer while stimulating the patient’s immune system.
Explore BioEclipse's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.